ATNM Actinium Pharmaceuticals Inc

$ATNM a whopping $42 million of market cap here…if there is any inkling that this is REAL the first stop should be $200 million or about $6 a share…then up from there as it is proved….

$ATNM Does anyone really believe that ATNM would be broadcasting a PR about their oral presentation on ATNM-400 if it was bad news? I certainly don’t!

$ATNM MANY-DISRUPTIVE UNMET NEEDS STARING AT US ALL RIGHT NOW!!!!AND THIS LITTLE NY COMPANY IS GOING TO MAKE HISTORY!!!!!!WHAT A COMEBACK WHAT A GREAT FEELING!!!!WHAT WE NEED IS CONTINUED TEAM WORK!COMMITMENT!FAITH!BELIEF!WE ARE GOING TO MAKE IT!THE PATIENTS ARE THE BRAVEST!THE SCIENCE WILL NOT FAIL THEM!BE STRONG ALL!

$ATNM loving this stock action today…… per tOMORROW………B U Y & H O L D!!!!!! Now…..partnerships coming!

$ATNM BIG ATNM-400 development. New EANM’26 abstracts confirm ATNM-400 has entered first-in-human clinical development. The Phase 1 mCRPC study says dose escalation is ongoing, with interim human safety, PK, biodistribution and dosimetry data to be presented at EANM. RADIANZ is also enrolling across 5 solid tumors: prostate, NSCLC, breast, colorectal & ovarian. October deck still guides to initial human biodistribution/safety data + target disclosure in Q4. EANM: Oct 17–21. Target remains undisclosed. Human data are coming.

$ATNM Patience…bought some more in premarket at 1.20.Patience…You have to be impressed by the support NCI has for ATNM. It can not continue to sell for cash on hand if any of va the ATNM story comes to fruition. I think/hope/ pray it is going to be an explosive ride!

$ATNM I’m all in so far from objective . I’m befuddled why no new large investors have come aboard. If the trials confirm what ATNM says is the science the market is immense. I will not put a value on it because it would sound stupid given the stock is trading at a $1. I hope if c the results are good we can do a better job of selling the story.Hoping for a big Christmas season

$ATNM Gemini Pro will tell you that only 5-10% of all abstracts at this conference are selected for oral presentations. And ATNM has been given a prime time slot.

$ATNM From AI Highly Disruptive! Massive leap forward!! “For a radiopharmaceutical company like Actinium, a preclinical oral slot indicates that the scientific committee views the data as highly disruptive. In the case of ATNM-400 in NSCLC, showing mutation-agnostic efficacy across both KRAS and ALK models represents a massive leap forward for targeted alpha therapies, which historically struggled to prove broad solid-tumor utility.”

$ATNM the hiring and announcements do not seem like a company preparing to fold - quite the opposite. They know something huge is on the horizon and are pushing forward. This is quite positive.

$ATNM I continue to be dumbfounded that people (including Shorts) would sell their shares for pennies when we literally have the potential of a major catalyst coming in approximately 2 more trading days…it just doesn’t make any sense for anyone to sell!

$ATNM If it wasn’t so sad, it would be laughable that inpatient people are giving their shares away for pennies BEFORE hearing the news from EANM presentations (Yes…we have more than one presentation…which is very rare)! Please don’t take the bait!!!…people are hoping that you don’t fully understand and appreciate the asset (shares) you own and will sell them! DON’T DO IT!!! You’ll hate yourself for it later IMHO!

$ATNM More than anyone outside expected: "The acknowledgements slide from today's presentation confirms that ATNM-400's RADIANZ study is a robust multi-center Australian clinical program — not a pilot. Five sites. Three states. Multiple patients. Already enrolling."

$ATNM NEWS OUT -(Actinium or the Company), a pioneer in differentiated targeted radiotherapies with the potential to transform cancer treatment, today reminded investors and the scientific community that clinical and preclinical data for ATNM-400 will be presented today at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM), being held October 17–21, 2026, in Vienna, Austria.

$ATNM The Change of Control severance clause in Matt David's offer letter is the fourth independent legal document in six weeks confirming ATNM's board expects a Change of Control: September 2: RSU grants to Seth — CoC acceleration September 2: RSU grants to all five directors — CoC acceleration October 15: Matt David CFO offer letter — CoC severance October 15 (8-K): Public SEC filing disclosing CoC severance to all shareholders Four legal documents in six weeks. All confirming the same event.

$ATNM From this stock value, the only way out is with favorable phase 1 data, that's all that's needed. I expect Selt to present that data in the coming days.

$ATNM THANK YOU JOHNNY FOR ALL YOUR EXPERTISE AND HARD WORK!!!!!!MANY HRS AND DAYS MONTHS WORTH OF INVESTAGATIVE ANALYSIS!!!!!I TRULY APPRECIATE YOU!!!!!!BUYING MORE SHARES IN THE NEAR FUTURE!!!!!!!!!!!!!!!!!!THANK YOU SO MUCH!!!!!!🍀🍀🍀🍀🍀🍀🍀to you always,looking forward to meeting you some day……..

$ATNM You can always just fast forward my posts if you do not agree, nobody said you have to read. Good reading my friends!!!

$ATNM Thank you Johnny for all your informative posts. As a long time shareholder it is exciting to see the company have multiple products and trials progressing all around the world. I think Seth has done a very good job developing these products with give or take 40 employees. He has done a terrible job building shareholder equity but hopefully that will change in the next 12 months. I like I suspect Johnny and others on this board would welcome opposing views which are based on the science and not personal dribble attacks on Seth.

$ATNM Looks like a SLS setup here before it skyrocketed on good readouts and partnership speculation